Finally, although these results do not support the addition of NEP inhibition to AT1R antagonism against experimental AngII-induced hypertension, atherosclerosis, or AAA formation, this drug combination may have benefit against other modes of inducing these cardiovascular diseases. The gene discussed is AGT; the disease is Hypertension.